We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$6.98M
Cap. Flow
-$27.2M
Cap. Flow %
-8.32%
Top 10 Hldgs %
35.72%
Holding
92
New
32
Increased
20
Reduced
19
Closed
20

Top Buys

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$9.19M
2
SNY icon
Sanofi
SNY
+$6.44M
3
ABT icon
Abbott
ABT
+$6.09M
4
CNC icon
Centene
CNC
+$5.9M
5
EHTH icon
eHealth
EHTH
+$5.67M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$13.7M
2
LHCG
LHC Group LLC
LHCG
+$9.87M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.03M
4
DHR icon
Danaher
DHR
+$7.96M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$7.65M

Sector Composition

Rank Sector Weight
1 Healthcare 85.4%
2 Energy 4.88%
3 Financials 1.69%
4 Consumer Discretionary 0.59%
5 Technology 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
51
Edwards Lifesciences
EW
$54B
$2.4M 0.73%
+30,000
New +$2.34M
HZNP
52
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.33M 0.71%
30,000
-50,000
-63% -$3.44M
MGNX icon
53
MacroGenics
MGNX
$249M
$2.27M 0.69%
90,000
+20,000
+29% +$546K
ZLAB icon
54
Zai Lab
ZLAB
$2.92B
$2.08M 0.64%
+25,000
New +$2.01M
ACHC icon
55
Acadia Healthcare
ACHC
$2.9B
$2.06M 0.63%
+70,000
New +$2.03M
GKOS icon
56
Glaukos
GKOS
$10.7B
$1.98M 0.61%
+40,000
New +$1.76M
CHWY icon
57
Chewy
CHWY
$9.2B
$1.92M 0.59%
+35,000
New +$1.89M
SWAV
58
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.9M 0.58%
+25,000
New +$1.42M
DTIL icon
59
Precision BioSciences
DTIL
$207M
$1.85M 0.57%
+10,000
New +$1.99M
KNSA icon
60
Kiniksa Pharmaceuticals
KNSA
$6.07B
$1.84M 0.56%
+120,000
New +$2.25M
GNMK
61
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.77M 0.54%
125,000
+25,000
+25% +$382K
KURA icon
62
Kura Oncology
KURA
$882M
$1.53M 0.47%
+50,000
New +$1.1M
DRNA
63
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.44M 0.44%
80,000
-30,000
-27% -$621K
PTCT icon
64
PTC Therapeutics
PTCT
$6.15B
$1.41M 0.43%
30,100
+100
+0.3% +$4.92K
GOSS icon
65
CALL
Gossamer Bio
GOSS
$88.9M
$1.24M 0.38%
+100,000
New +$1.33M
INO icon
66
PUT
Inovio Pharmaceuticals
INO
$79.1M
$1.16M 0.35%
+8,333
New +$1.74M
GMAB icon
67
Genmab
GMAB
$19.2B
$1.1M 0.34%
+30,000
New +$1.08M
MCRB icon
68
Seres Therapeutics
MCRB
$46.6M
$849K 0.26%
+1,500
New +$499K
INSM icon
69
Insmed
INSM
$29B
$804K 0.25%
+25,000
New +$719K
CHNG
70
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$726K 0.22%
50,000
-200,000
-80% -$2.54M
MYOV
71
DELISTED
Myovant Sciences Ltd.
MYOV
$703K 0.22%
+50,000
New +$930K
ALEC icon
72
Alector
ALEC
$233M
$316K 0.1%
+30,000
New +$485K
ABBV icon
73
AbbVie
ABBV
$442B
– –
-25,000
Closed -$2.46M
AKBA icon
74
Akebia Therapeutics
AKBA
$240M
– –
-250,000
Closed -$3.4M
AMGN icon
75
Amgen
AMGN
$224B
– –
-25,000
Closed -$5.9M
1 2
3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Integral Health Asset Management held 92 positions worth $327M, down 2.1% from $334M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $27.2M in Q3 2020, closing 20 positions and reducing 19 holdings. Its most notable exit was Quest Diagnostics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Energy and Financials.

Against the trend, Integral Health Asset Management opened a new position in Sanofi worth $6.27M.

  • Integral Health Asset Management's largest Q3 2020 buy was Sanofi: 125,000 shares worth $6.27M.
  • Integral Health Asset Management added most to Revvity in Q3 2020, an estimated $9.19M increase.
  • Integral Health Asset Management's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $9.87M.
  • Integral Health Asset Management fully exited Quest Diagnostics in Q3 2020, selling an estimated $13.7M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $327M portfolio in Q3 2020.
  • Integral Health Asset Management opened 32 new positions and closed 20 in Q3 2020.
  • Integral Health Asset Management's portfolio value fell 2.1% quarter-over-quarter to $327M.

Based on Integral Health Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.